Patent details

Basic Information

Publication number:

EP3189855

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP163860018

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORAL PHARMACEUTICAL SOLUTIONS CONTAINING HYDROCORTISONE SODIUM PHOSPHATE

French Title of Invention:

SOLUTIONS PHARMACEUTIQUES ORALES DE PHOSPHATE DE SODIUM CONTENANT DE L'HYDROCORTISONE

German Title of Invention:

ORALE PHARMAZEUTISCHE LÖSUNGEN MIT HYDROCORTISON-NATRIUM-PHOSPHAT

SPC Number:

Dates

Filing date:

11/01/2016

Grant date:

21/03/2018

EP Publication Date:

12/07/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/03/2018

EP B1 Publication Date:

21/03/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/01/2019

Expiration date:

11/01/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/03/2018

 

 

Name:

Lamda Laboratories S.A.

Address:

59, Ioannou Metaxa Str. Karellas, 19400 Koropi,, Attiki, Greece (GR)

Inventor

1

Name:

Resvani, Amalia

Address:

Greece (GR)

2

Name:

Karatzas, Angelos

Address:

Greece (GR)

3

Name:

Loukas, Agathoklis

Address:

Greece (GR)

4

Name:

Apostolou, Konstantinos

Address:

Greece (GR)

5

Name:

Stappa, Argyro

Address:

Greece (GR)

Classification

IPC classification:

A61K 9/08; A61K 31/661; A61K 47/26; A61K 47/10;

Publication

European Patent Bulletin

Issue number:

201812

Publication date:

21/03/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/05/2019	Outgoing Correspondence	1